NIH Researchers Make Progress In HIV Vaccine Development

“At the Vaccine Research Center at the [NIH], researchers have developed high-resolution images of the AIDS virus at the atomic level,” columnist Michael Gerson writes in a Washington Post opinion piece. He describes this research and the advances scientists have made in learning how to prevent HIV from infecting cells. “The goal is a vaccine that causes the body itself to produce the needed antibodies” to destroy the virus, he writes, adding, “All this matters directly to the 2.3 million people infected with [HIV] each year — including a quarter of a million children. But it is also a tribute to the tenacity and importance of the scientific enterprise.” Gerson concludes, “HIV/AIDS emerged in the early 1980s as a nameless fear, which some initially thought could be transmitted by casual contact. Scientists identified the disease’s true avenues of transmission, researched the antiretroviral drugs that have rendered it a chronic condition for many and have now identified its vulnerabilities at the atomic level — a development that may help understand and counter the next nameless fear” (12/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.